| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the First Cardiovascular Division and the Department of Public Health, Chang Gung College of Medicine and Technology and Chang Gung Memorial Hospital, Taipei, Taiwan, ROC.
Few predictors of systemic embolism in patients with mitral stenosis have been identified by noninvasive methods. This study used the most powerful noninvasive diagnostic tool, transthoracic echocardiography, as well as other noninvasive clinical information to look for predictors. Five hundred consecutive patients with a mitral valve area of 2 cm2 or less were studied. They were divided into two groups: group 1 consisted of 143 patients with a history of systemic embolism and group 2 consisted of 357 patients with no history of systemic embolism. Using a stepwise logistic regression on a random subsample of 400 patients, 4 independent predictors were found: the presence of atrial fibrillation (p=0.003, relative risk [RR]=2.3, 95% CI=1.3, 4.2), the absence of significant tricuspid regurgitation (p=0.008, RR=2.5, 95% CI=1.3, 4.9), the absence of aortic regurgitation (p=0.022, RR=2.2, 95% CI=1.1, 4.2), and the presence of left atrial smoky echoes (p=0.039, RR=1.7, 95% CI=1.1, 3.0). When the above model, together with significant interaction terms, was applied to the remaining 100 patients, both the Hosmer-Lemeshow and Brown goodness-of-fit statistics were not significant (p=0.888 and p=0.248, respectively), indicating that the fit was adequate and the model was validated. Thus, important noninvasive predictors of systemic embolism in patients with mitral stenosis can easily be obtained. Subgroups of patients with high risk of systemic embolism can be identified. This may refine our therapeutic strategies to prevent the catastrophe of systemic embolism.
Submitted on August 11, 1993
This article has been cited by other articles:
|
|
 |
|
  B. Olshansky, E. N. Heller, L. B. Mitchell, M. Chandler, W. Slater, M. Green, M. Brodsky, P. Barrell, H. L. Greene, and and the AFFIRM Investigators Are Transthoracic Echocardiographic Parameters Associated With Atrial Fibrillation Recurrence or Stroke?: Results From the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study J. Am. Coll. Cardiol., June 21, 2005; 45(12): 2026 - 2033. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-C. Chen, C.-J. Wu, H.-W. Chang, H.-K. Yip, Y.-H. Chen, C.-I Cheng, and H.-T. Chai Mechanism of Reducing Platelet Activity by Percutaneous Transluminal Mitral Valvuloplasty in Patients With Rheumatic Mitral Stenosis Chest, May 1, 2004; 125(5): 1629 - 1634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-C. Chen, C.-J. Wu, H.-K. Yip, H.-W. Chang, C.-Y. Fang, T.-H. Yu, and M. Fu Left Atrial Platelet Activity With Rheumatic Mitral Stenosis: Correlation Study of Severity and Platelet P-Selectin Expression by Flow Cytometry Chest, November 1, 2003; 124(5): 1663 - 1669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. I. Fann, N. B. Ingels Jr., and D. C. Miller Pathophysiology of Mitral Valve Disease Card. Surg. Adult, January 1, 2003; 2(2003): 901 - 931. [Full Text]
|
|
|
|
 |
|
 K.M. Channon and A.P. Banning Echocardiography in stroke and thromboembolism: transoesophageal imaging for all? QJM, November 1, 1999; 92(11): 619 - 621. [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Peverill, R. W. Harper, J. Gelman, T. E. Gan, G. Harris, and J. J. Smolich Determinants of Increased Regional Left Atrial Coagulation Activity in Patients With Mitral Stenosis Circulation, August 1, 1996; 94(3): 331 - 339. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
